Physician profile
Flash A Gordon
NPI 1982666764
$2,114.93
in general payments reported to CMS, 2019-2025
14 companies · $310 in 2025
The $310 reported for 2025 was more than what 76% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $146 · 2022: $155 · 2023: $204 · 2024: $484 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $814.58 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Allergan, INC. | $438.39 | 2019-2020 | |
| Lilly USA, LLC | $384.56 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Boston Scientific Corporation | $162.93 | 2019 | |
| Amgen INC. | $109.85 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $37.74 | 2019-2022 | |
| Indivior INC. | $36.26 | 2019 | |
| Exact Sciences Corporation | $22.79 | 2023 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $20.98 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.47 | 2022 | |
| Astellas Pharma US INC | $19.72 | 2019 | |
| Eisai INC. | $19.01 | 2022 | |
| Alfasigma USA, INC. | $14.93 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Flash Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.